Skip to content

NARA

PanGenomic Health Inc

Access


ISIN

CA69842E2050

Bid

3.50

Mid

4.00

Ask

4.50

Key Information

Price Change
0.00%
Year High
4.50
Year Low
4.00
Market Cap
£3.97M
Par
0.00
Bid
3.50
Mid Price
4.00
Ask
4.50
Instrument Type
Ordinary Shares
MIFID Status
MTF
Tradable Securities
99.13M
Sector
Healthcare

Prices in GBX except for Market Cap in GBP

About PanGenomic Health Inc

The Company is a precision health company that has developed a self-care digital platform to deliver personalised, evidence-based information about natural treatments to support mental health. The Company has three platforms: Nara App - a mental health mobile app which provides consumers with a knowledge base tailored to an individual's unique user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics and microbiomic data. indleap.com - and app and telehealth platform for holistirc mental wellness which grants users access to great audio content and blogs, a mental health tracker, and access to professional services for mental well-being. The Company's digital therapeutics clinic platform, the PlantGx Platform, provides health practitioners with access to a consumer's Nara App data in order to assist them to optimize the identification of appropriate natural remedies and monitor a patient's prognosis during treatment. Mindleap.com was acquired in November 2022 when the Company purchased the entire issued share capital for Mindleap Health Inc from Mydecine Innovations Group Inc.

PanGenomic Health IncAccess

Latest Trades

DateVolumePrice (GBX)Value (GBP)

Latest Announcements

DateTitle

30 May 23

12:30

PanGenomic Health Inc - PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform

03 May 23

07:00

PanGenomic Health Inc - Annual Financial Results

02 May 23

08:34

PanGenomic Health Inc - AGM Results

24 Apr 23

07:00

PanGenomic Health Inc - Subsidiary Update and Repricing of Outstanding Warrants

12 Apr 23

07:00

PanGenomic Health Inc - Admission to Trading on AQSE and First Day of Dealings
View all announcements

Address

Registered Address

232 – 3800 Wesbrook Mall, Vancouver, British Columbia, V6S 2L9, Canada

Email

Phone

604-218-5788

Contacts

Corporate Adviser

Novum Securities, 2nd Floor Lansdowne House, 57 Berkeley Square, London, W1J 6ER, United Kingdom

Registrar

Link Group, 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL, United Kingdom
Loading...

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2023. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal